RPHM
Price:
$18.2
Market Cap:
$60.84M
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Industry
Biotechnology
IPO Date
2021-04-08
Stock Exchange
NASDAQ
Ticker
RPHM
According to Reneo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 38.83%. This represents a change of 401.37% compared to the average of 7.74% of the last 4 quarters.
The mean historical ROE of Reneo Pharmaceuticals, Inc. over the last ten years is -10.74%. The current 38.83% ROE has changed -461.53% with respect to the historical average. Over the past ten years (40 quarters), RPHM's ROE was at its highest in in the December 2024 quarter at 35.96%. The ROE was at its lowest in in the December 2023 quarter at -26.58%.
Average
-10.74%
Median
-13.51%
Minimum
-87.34%
Maximum
53.77%
Discovering the peaks and valleys of Reneo Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 85.36%
Maximum Annual ROE = 53.77%
Minimum Annual Increase = -158.45%
Minimum Annual ROE = -87.34%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0% | -100.00% |
| 2023 | -87.34% | 74.40% |
| 2022 | -50.08% | 85.36% |
| 2021 | -27.02% | -158.45% |
| 2020 | 46.22% | -14.05% |
The current ROE of Reneo Pharmaceuticals, Inc. (RPHM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-45.80%
5-year avg
-23.64%
10-year avg
-10.74%
Reneo Pharmaceuticals, Inc.’s ROE is greater than Achilles Therapeutics plc (-32.91%), greater than Heat Biologics, Inc. (-1764.70%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Surface Oncology, Inc. (-61.52%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than Kronos Bio, Inc. (-64.22%), greater than Quince Therapeutics, Inc. (-186.08%), greater than The Valens Company Inc. (-25.35%), greater than AlloVir, Inc. (-76.00%), greater than Rein Therapeutics Inc. (-217.16%),
| Company | ROE | Market cap |
|---|---|---|
| -32.91% | $60.83M | |
| -1764.70% | $61.07M | |
| -71.90% | $58.11M | |
| -61.52% | $65.08M | |
| -74.73% | $56.22M | |
| -64.22% | $53.65M | |
| -186.08% | $214.65M | |
| -25.35% | $61.46M | |
| -76.00% | $49.48M | |
| -217.16% | $36.01M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reneo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Reneo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Reneo Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Reneo Pharmaceuticals, Inc. (RPHM)?
What is the highest ROE for Reneo Pharmaceuticals, Inc. (RPHM)?
What is the 3-year average ROE for Reneo Pharmaceuticals, Inc. (RPHM)?
What is the 5-year average ROE for Reneo Pharmaceuticals, Inc. (RPHM)?
How does the current ROE for Reneo Pharmaceuticals, Inc. (RPHM) compare to its historical average?